* determines 1989 world series Long end as pants recounts leads rise in Treasury prices Bonds  |  France * Month- and quarter-end rebalancing driving gains * Job data on Thursday may curtail rally By Mary Angela Rowe NEW YORK, June 29 (Reuters) - U.S. Treasury prices rose onMonday, extending last week's rally, as investors prepare tosquare their positions before the end of the month and thesecond quarter. Bonds' gains were led by 30-year Treasuries as fundmanagers scrambled to add longer maturities investments tomatch their portfolio benchmarks' duration. "Magic Quadrant for Content-Aware Data Loss Prevention"by Eric Ouellet and Paul Proctor, June 29, 2009.Media Contact:Cas PurdyDirector, Public RelationsWebsense, Inc.Email: Phone: (858) 320-9493Copyright 2009, Market Wire, All rights reserved.-0-.

Duration is a measure of the sensitivity of a bond's priceto changes in interest rates anthony recker . Duration is measured in years,and the longer the duration of a portfolio, the riskier it is as ring . "A lot of the rally today is a function of month-end,quarter-end and half-year buying as shirt . Index funds need to extendduration and they do that via purchasing longer-datedTreasuries," said Kim Rupert, managing director of globalfixed-income at Action Economics LLC in San Francisco as shirts . But trading was thin as some investors wait warily foreconomic data, especially June's non-farm payrolls report fromthe Labor Department on Thursday, to set the market's tone. June's Treasury auctions have flooded the market withroughly $176 billion in longer-dated new supply, including $11billion 30-years. The 30-year bond price US30YT=RR rose 19/32 for a yieldof 4.30 percent, compared to a yield of 4.34 percent at theclose on Friday.

Benchmark ten-year prices US10YT=RRincreased 15/32 points to yield 3.49 percent, down from a yieldof 3.54 percent on Friday as ball . LONG-END DILEMMA Despite these gains, Treasuries are still theworst-performing sector in the U.S bond market U.S as tee . government debt has posted a loss of 4.25 percent sofar this year, according to Barclays Capital Treasuries arethe only types of U.S as tees . bonds which lost value on month-to-dateand year-to-date after a stellar 2008 as toy . Long bonds, in particular, proved unrewarding forinvestors, as U.S.

Treasuries with 20 or more years untilmaturity lost 19.08 percent to date in 2009 as beding . Telesat Canada Commences Registered Exchange Offer for Its 11.0% Senior NotesDue 2015 and 12.5% Senior Subordinated Notes Due 2017OTTAWA, June 29, 2009 (GLOBE NEWSWIRE) -- Telesat Canada today announced anoffer to exchange (1) any and all of the US$692,825,000 outstanding principalamount of its 11.0% Senior Notes due 2015 for an equal amount of new 11.0%Senior Notes due 2015 and (2) any and all of the US$217,175,000 outstandingprincipal amount of its 12.5% Senior Subordinated Notes due 2017 for an equalamount of new 12.5% Senior Subordinated Notes due 2017 Telesat LLC is, and willbe, the co-issuer of the notes as toys . We disclaim any obligation to publicly update or revise anysuch statements to reflect any change in expectations or in events, conditionsor circumstances on which any such statements may be based, or that may affectthe likelihood that actual results will differ from those set forth in theforward-looking statements.AMAG Pharmaceuticals, Inc.Kristen Galfetti, Copyright Business Wire 2009 as pants . We caution you not to placeundue reliance on any forward-looking statements, which speak only as of thedate they are made as ring . Such risks and uncertainties include: (1) the possibilitythat we may not be able to adequately address the issues raised and provide theinformation requested in the Feraheme Complete Response letters, (2)uncertainties regarding our ability to manufacture Feraheme, (3) the fact thatwe have limited sales and marketing expertise, (4) uncertainties regarding ourability to successfully compete in the intravenous iron replacement and imagingmarkets, (5) uncertainties regarding our ability to obtain favorable coverage,pricing and reimbursement for Feraheme, if approved, (6) uncertainties relatingto our patents and proprietary rights, and (7) other risks identified in ourSecurities and Exchange Commission filings, including our Annual Report on Form10-K for the fiscal year ended December 31, 2008. Any statements contained herein which do not describe historical facts,including but not limited to, statements regarding our expectation that the FDAwill issue an action letter with respect to the Feraheme NDA in the next fewdays and that there are no outstanding issues regarding the Feraheme NDA, areforward looking statements which involve risks and uncertainties that couldcause actual results to differ materially from those discussed in such forwardlooking statements.

Forward Looking StatementThis press release contains forward-looking statements within the meaning of thePrivate Securities Litigation Reform Act of 1995 and other federal securitieslaws as cap . Feraheme (ferumoxytol) Injection is being developed for use as an intravenousiron replacement therapeutic agent for the treatment of iron deficiency anemiaand as a diagnostic agent for vascular-enhanced magnetic resonance imaging toassess peripheral arterial disease as shirt . is a biopharmaceutical company that utilizes itsproprietary technology for the development and commercialization of atherapeutic iron compound to treat anemia and novel imaging agents to aid in thediagnosis of cancer and cardiovascular disease as shirts . An audio webcast of the call will be available through the Investors section ofthe Company`s website at A replay of the webcast will alsobe available from approximately 10:30 a.m ET on June 30, 2009, through midnightJuly 6, 2009 About AMAG Pharmaceuticals, Inc.AMAG Pharmaceuticals, Inc . To access a replay of the conference call, dial (800) 642-1687from the U.S or (706) 645-9291 for international access The passcode for thelive call and the replay is 17087311. A telephone replay will beavailable from approximately 11:30 a.m ET on June 30, 2009 through midnightJuly 2, 2009.

Comments are closed.

Subscribe to Feed

  • Entries (RSS)
  • Comments (RSS)

Categories

Featured Sponsors